Rezolute, Inc.
Total Trades
31
Buys
30
Sells
0
Largest Trade
N/A
Insiders
8
Institutional Funds
91
Inst. Value
$1M+
Activist Filings
30
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Hogenhuis Wladimir | Director | BUY | $1K–$15K | 6K | $1.69 | Dec 17, 2025 |
| ROBERTS BRIAN KENNETH | Chief Medical Offi… | BUY | $15K–$50K | 28K | $1.70 | Dec 17, 2025 |
| Evans Daron | CFO | BUY | $50K–$100K | 45K | $1.77 | Dec 16, 2025 |
| Elam Nevan C | CEO | BUY | $50K–$100K | 32K | $1.59 | Dec 16, 2025 |
| Karnawat Sunil Ratilal | Chief Commercial O… | BUY | $15K–$50K | 12K | $1.62 | Dec 16, 2025 |
| ROBERTS BRIAN KENNETH | Chief Medical Offi… | BUY | $1K–$15K | 3K | $4.38 | Jun 26, 2025 |
| Evans Daron | CFO | BUY | $15K–$50K | 5K | $4.05 | Jun 24, 2025 |
| Kim Young-Jin | Director | BUY | $1M+ | 1.2M | $3.25 | Jun 23, 2025 |
| KREHER NERISSA | Director | BUY | $1K–$15K | 3K | $3.25 | Jun 23, 2025 |
| Hogenhuis Wladimir | Director | BUY | $15K–$50K | 7K | $2.92 | Apr 1, 2025 |
| Elam Nevan C | CEO | BUY | $15K–$50K | 12K | $2.85 | Mar 31, 2025 |
| Evans Daron | CFO | BUY | $50K–$100K | 20K | $2.88 | Mar 28, 2025 |
| Hogenhuis Wladimir | Director | GRANT | N/A | 26K | — | Feb 21, 2025 |
| Hogenhuis Wladimir | Director | BUY | $15K–$50K | 10K | $4.70 | Feb 21, 2025 |
| Hogenhuis Wladimir | Director | BUY | $15K–$50K | 4K | $4.70 | Sep 24, 2024 |
| Hogenhuis Wladimir | Director | BUY | $15K–$50K | 5K | $4.15 | Jun 27, 2024 |
| ROBERTS BRIAN KENNETH | Chief Medical Offi… | BUY | $15K–$50K | 8K | $3.91 | Jun 14, 2024 |
| Evans Daron | CFO | BUY | $100K–$500K | 40K | $4.04 | Jun 14, 2024 |
| Evans Daron | CFO | BUY | $1K–$15K | 451 | $3.50 | May 31, 2024 |
| ROBERTS BRIAN KENNETH | Chief Medical Offi… | BUY | $15K–$50K | 8K | $2.69 | May 28, 2024 |
| Evans Daron | CFO | BUY | $1K–$15K | 3K | $3.22 | May 28, 2024 |
| ROBERTS BRIAN KENNETH | Chief Medical Offi… | BUY | $1K–$15K | 500 | $2.55 | Mar 29, 2024 |
| Elam Nevan C | CEO | BUY | $1K–$15K | 5K | $1.68 | Feb 28, 2024 |
| ROBERTS BRIAN KENNETH | Chief Medical Offi… | BUY | $1K–$15K | 8K | $1.69 | Feb 27, 2024 |
| ROBERTS BRIAN KENNETH | Chief Medical Offi… | BUY | $1K–$15K | 7K | $1.31 | Feb 21, 2024 |
| Evans Daron | CFO | BUY | $50K–$100K | 51K | $1.31 | Feb 20, 2024 |
| ROBERTS BRIAN KENNETH | Chief Medical Offi… | BUY | $1K–$15K | 5K | $1.90 | Jul 6, 2023 |
| ROBERTS BRIAN KENNETH | Sr VP | BUY | $1K–$15K | 2K | $3.24 | May 19, 2022 |
| ROBERTS BRIAN KENNETH | Sr VP | BUY | $50K–$100K | 21K | $3.80 | May 6, 2022 |
| Labrucherie Gil M | Director | BUY | $100K–$500K | 53K | $3.80 | May 6, 2022 |
| Hogenhuis Wladimir | Director | BUY | $100K–$500K | 33K | $4.44 | May 6, 2022 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 91 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| FEDERATED HERMES, INC. | 16.5M | $1M+ | SH |
| RA CAPITAL MANAGEMENT, L.P. | 9.2M | $1M+ | SH |
| BALYASNY ASSET MANAGEMENT L.P. | 4.5M | $1M+ | SH |
| STATE STREET CORP | 4.0M | $1M+ | SH |
| UBS Group AG | 2.8M | $1M+ | SH |
| Affinity Asset Advisors, LLC | 2.4M | $1M+ | SH |
| BARCLAYS PLC | 1.9M | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 1.7M | $1M+ | SH |
| JANE STREET GROUP, LLC | 1.1M | $1M+ | SH |
| 22NW, LP | 821K | $1M+ | SH |
| Velan Capital Investment Management LP | 750K | $1M+ | SH |
| KENNEDY CAPITAL MANAGEMENT LLC | 698K | $1M+ | SH |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 665K | $1M+ | SH |
| TUDOR INVESTMENT CORP ET AL | 610K | $1M+ | SH (Put) |
| Centiva Capital, LP | 407K | $500K+ | SH (Call) |
| HRT FINANCIAL LP | 374K | $500K+ | SH |
| Knott David M Jr | 340K | $500K+ | SH |
| Caitong International Asset Management Co., Ltd | 209K | $100K–$500K | SH |
| Caitong International Asset Management Co., Ltd | 209K | $100K–$500K | SH |
| PFM Health Sciences, LP | 206K | $100K–$500K | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G/A · Feb 13, 2026
0.0%
0 shares
SC 13G · Feb 11, 2026
6.5%
6.1M shares
SC 13G · Jan 30, 2026
5.2%
4.8M shares
SC 13G/A · Jan 8, 2026
2.5%
2.3M shares
SC 13G · Dec 19, 2025
5.3%
4.9M shares
SC 13G · Dec 18, 2025
9.9%
9.2M shares
SC 13G · Oct 17, 2025
5.4%
4.9M shares
SC 13G · Sep 22, 2025
4.6%
4.2M shares
SC 13G/A · Aug 6, 2025
15.0%
12.8M shares
SC 13G · Mar 7, 2025
10.5%
6.4M shares
Nantahala Capital Management, LLC
SC 13G/A · Feb 14, 2025
4.9%
2.9M shares
Vivo Opportunity Fund Holdings, L.P.
SC 13G/A · Nov 14, 2024
4.8%
2.8M shares
Nantahala Capital Management, LLC
SC 13G/A · Nov 14, 2024
8.6%
5.0M shares
SC 13G/A · Nov 14, 2024
0.0%
0 shares
Stonepine Capital Management, LLC
SC 13G/A · Nov 13, 2024
0.0%
0 shares
Adage Capital Management, L.P.
SC 13G/A · Nov 12, 2024
4.9%
2.8M shares
Nantahala Capital Management, LLC
SC 13G · Mar 11, 2024
9.9%
4.1M shares
Vivo Opportunity Fund Holdings, L.P.
SC 13G/A · Feb 13, 2024
8.2%
3.2M shares
Stonepine Capital Management, LLC
SC 13G/A · Feb 13, 2024
7.0%
2.8M shares
SC 13G/A · Feb 12, 2024
6.8%
2.7M shares
SC 13G/A · Jan 18, 2024
20.0%
8.3M shares
Vivo Opportunity Fund Holdings, L.P.
SC 13G · Oct 13, 2023
8.8%
3.2M shares
SC 13G · Feb 14, 2023
8.5%
3.1M shares
SC 13G/A · Feb 14, 2023
5.0%
1.9M shares
Stonepine Capital Management, LLC
SC 13G/A · Feb 13, 2023
8.2%
3.0M shares
SC 13G/A · Feb 1, 2023
20.0%
7.6M shares
SC 13G · Jun 27, 2022
8.8%
3.2M shares
SC 13G/A · Feb 14, 2022
8.6%
1.3M shares
(entities only Federated Hermes, Inc.
SC 13G/A · Feb 14, 2022
20.7%
3.2M shares
Stonepine Capital Management, LLC
SC 13G/A · Feb 11, 2022
5.2%
808K shares